📰 Lymph Node News
Page 11 - Lymph Node News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lymph Node. Real-time updates on events, politics, business and more.
February 1, 2022
A new study led by academics at King’s and Guy’s and St Thomas’ NHS Foundation Trust is using historical scans to evaluate how AI-driven diagnostic
January 21, 2022
Melanoma cells release small extracellular packages containing the protein nerve growth factor receptor, which primes nearby lymph nodes for tumor metastases, according to a new study by Weill Cornell Medicine investigators.
January 4, 2022
The US Food and Drug Administration gave emergency use authorization for booster doses of Pfizer/BioNTechs Covid-19 vaccine for children ages 12 to 15 Monday.
January 4, 2022
The US Food and Drug Administration gave emergency use authorization for booster doses of Pfizer/BioNTechs Covid-19 vaccine for children ages 12 to 15 Monday.
January 2, 2022
Roanoke County Board of Supervisors Chair Jason Peters tries to move forward in the face of adversity.
December 7, 2021
In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.
December 5, 2021
Examination of Japanese cases of gynecological cancer offers a better understanding of the profile of a rare ovarian tumor and could change treatment guidelines.
November 26, 2021
An international collaboration involving researchers from Queen Mary University of London, Memorial Sloan Kettering Cancer Center, New York and Dana-Farber Cancer Institute, Boston has secured a €1M research grant from Dutch blood cancer charity, Lymph&Co, to investigate a new treatment target for lymphoma.
November 24, 2021
A new type of peptide receptor radionuclide therapy (PRRT) has been shown to control disease in 85 percent of patients with metastatic neuroendocrine neoplasms, achieving complete remission in some patients.
October 11, 2021
Chronic wasting disease has been confirmed in a hunting district just south of Yellowstone National Park, the Wyoming Game and Fish Department announced in a Monday press release.